The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule.
Previous studies have shown that alpha-fetoprotein (AFP) interferes with estrogen (E2)-stimulated growth, including E2-stimulated breast cancer growth. In an effort to localize the antiestrotrophic portion of the molecule, the C-terminal one-third (200 amino acids) of human AFP, known as Domain III, was produced in a baculovirus expression system as a fusion protein containing an amino terminal histidine tag. The histidine tag was included to facilitate purification by metal ion affinity chromatography. The purified recombinant Domain III fusion protein was functionally similar to full-length natural AFP isolated from human cord sera or from cultured human hepatoma cells (HepG2) in that they all produced significant and quantitatively similar inhibition of E2-stimulated growth of immature mouse uterus. Furthermore, the dose-response profiles of the recombinant Domain III AFP and natural full-length AFP were similar. Preincubation of either protein in a molar excess of E2 lowered the minimally effective antiestrotrophic dose and produced a difference spectrum consistent with a change in conformation. These findings indicate that the antiestrotrophic activity of AFP is contained within the third domain of the molecule, and they have obvious implications for the production of biologically active peptides derived from this portion of the AFP molecule.
Festin
S M
SM
Department of Biochemistry and Molecular Biology, Mail Code 10, Albany Medical College, 47 New Scotland Avenue, Albany, NY 12208, USA.
Bennett
J A
JA
Fletcher
P W
PW
Jacobson
H I
HI
Shaye
D D
DD
Andersen
T T
TT
D000818:Animals; D016367:Baculoviridae / Q000235:genetics; D001665:Binding Sites; D003001:Cloning, Molecular; D018076:DNA, Complementary / Q000737:chemistry / Q000235:genetics; D004965:Estrogen Antagonists / Q000737:chemistry* / Q000494:pharmacology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006639:Histidine / Q000737:chemistry; D006801:Humans; D051379:Mice; D010446:Peptide Fragments / Q000096:biosynthesis / Q000737:chemistry; D011994:Recombinant Proteins / Q000737:chemistry; D013056:Spectrophotometry, Ultraviolet; D014599:Uterus / Q000187:drug effects / Q000254:growth & development; D000509:alpha-Fetoproteins / Q000096:biosynthesis / Q000737:chemistry* / Q000235:genetics
D018076:DNA, Complementary; D004965:Estrogen Antagonists; D004967:Estrogens; D010446:Peptide Fragments; D011994:Recombinant Proteins; D000509:alpha-Fetoproteins; D006639:Histidine